Not every hot ophthalmology innovation is built to stand the test of time.
Roy Rubinfeld, MD, MA, has seen many come and go over the years.
“You see these articles in peer-reviewed journals about a new epithelium-on cross-linking system, and everyone gets all excited,” he said. “Over time, you start to wonder, ‘Whatever happened to that great innovation?’ Well, it didn’t work out. In fact, several meta-analyses of more than a decade of the world’s literature on epi-on CXL techniques have shown inferior results. That is, until now.”
“Keratoconus